The goal of the Diabetes Research Center is to foster and support both basic and clinical research in diabetes and related metabolic disorders with the ultimate purpose of translating findings into opportunities to prevent these diseases and to improve clinical care and outcomes.

The American Medical Association, American Nurses Association and more than 50 other health care organizations are asking for a COVID-19 vaccine mandate for all US health care workers in an effort to bolster vaccination levels and reduce spread of the Delta variant. “This is the logical fulfillment of the ethical commitment of all health care workers to put patients as well as residents of long-term care facilities first and take all steps necessary to ensure their health and well-being,” the groups said in a statement.

Full Story: The Washington Post (tiered subscription model) (7/26),  The Hill (7/26)  

A study published in The Lancet Diabetes & Endocrinology linked gastric bypass, vertical-banded gastroplasty and gastric banding to a higher risk of anemia. “These findings highlight the importance of long-term compliance to nutritional supplementation and monitoring to enable prevention and early detection of serious nutritional deficiencies after bariatric surgery,” researchers wrote.

 Full Story: Healio (free registration)/Endocrine Today (7/21)  

AstraZeneca’s extended-release drug Bydureon/Bydureon BCise, or exenatide, has gained FDA approval to treat pediatric patients with type 2 diabetes aged 10 years and older. The two Bydureon products differ in mixing procedure and delivery device.

Full Story: Medscape (free registration) (7/23)  

A study in The Lancet Healthy Longevity found that high levels of low-density lipoprotein in middle-age people is associated with an increased risk of developing dementia later in life. “In people with cholesterol measured below age 65, the risk of dementia being diagnosed more than 10 years later was about 60% higher in those with LDL cholesterol levels above 200 mg/dL compared to those with levels less than 100 mg/dL,” said Masao Iwagami, the study’s lead author.

 Full Story: Sky News (7/24)  

National Institute of Allergy and Infectious Diseases Director Anthony Fauci said he expects the three COVID-19 vaccines from Pfizer/BioNTech, Moderna and Johnson & Johnson, which were all granted emergency use authorization, to eventually receive full FDA approval, noting the vaccines show high efficacy in both clinical trials and real-world studies. The full approval, however, might “take a little bit more time,” Fauci added.

Full Story: CNBC (7/13)  

A study presented at the American Diabetes Association Scientific Sessions virtual meeting found that liraglutide and insulin performed better than sulfonylurea glimepiride and dipeptidyl peptidase-4 inhibitor sitagliptin in maintaining A1C levels below 7% among adults with type 2 diabetes. The findings, based on data from 5,000 participants, remained similar between men and women, as well as across various age groups, races and ethnicities.

 Full Story: Medical Dialogues (7/14)  

A study in Diabetes Care found that adults with type 1 diabetes who used a tubeless, on-body automated insulin delivery system with customizable glycemic targets for three months experienced reductions in hypoglycemia, compared with those who received standard therapy. The findings, based on data from 235 patients with type 1 diabetes, also showed that both children and adults who used the system had better time in range and lower A1C.

 Full Story: Medical Dialogues (7/3)  

Diabetes patients who were treated with sodium-glucose cotransporter 2 inhibitors had lower odds of incident and recurrent nephrolithiasis, compared with those who were treated with glucagon-like peptide-1 receptor agonists, according to a study in Diabetologia, based on data from 12,325 matched pairs of participants.

Full Story: Medical Dialogues (6/29)  

Patients with type 2 diabetes and obesity saw improvements in metabolic and inflammatory biomarkers after undergoing Roux-en-Y gastric bypass when compared to patients who did not undergo the surgery, according to a small study published in Diabetology & Metabolic Syndrome. The improvements were attributed to an increase of microbial richness and Proteobacterial lineages in the gut microbiome.

Full Story: Endocrinology Advisor (6/24)  

A study in Diabetes Care found a link between increases in systolic blood pressure and slight increases in the likelihood of cardiovascular disease, regardless of a person’s glucose tolerance status. The research, based on data from 805,992 individuals in Japan, also found a similar association between elevated diastolic blood pressure and higher cardiovascular disease risk.

 Full Story: Medical Dialogues (6/25)